Ariad Pharmaceuticals, a Cambridge, Massachusetts, company that specializes in the development of cancer treatments, is contributing to the biotechnology boom that is taking place across the United States. According to The Boston Globe, the firm is expanding its existing headquarters and plans to add workers in 2013.
However, Ariad is only one of the companies that is increasing its presence in the United States. The news outlet reports that Novartis AG, Millennium Pharmaceuticals and Biogen Idec are among the biotechnology firms that are improving their laboratories and offices.
In St. Louis, Missouri, a special biotechnology workshop will be held to promote the industry to job seekers. The St. Louis Business Journal notes that the event will take place on February 4, 2013, and industry experts will provide attendees with information about the expertise and skills that are required to find a job in the sector.
Growth in the biotechnology segment could dramatically affect the U.S. economy. If firms in this industry expand, they could provide enhanced solutions that could have far-reaching effects, and they may seek new staff members to fill important roles with their companies.